HYPERFIBRINOGENAEMIA

This adverse event was reported 67 times

These drugs are most commonly taken by patients reporting HYPERFIBRINOGENAEMIA:

# Drug Count
0 DOCETAXEL 13
1 DOCETAXEL ANHYDROUS 13
2 PERTUZUMAB 13
3 TRASTUZUMAB 13
4 BUSULFAN 12
5 CYCLOSPORINE 12
6 FLUDARABINE PHOSPHATE 12
7 MYCOPHENOLATE MOFETIL 12
8 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 12
9 THIOTEPA 12
See all common drugs associated with HYPERFIBRINOGENAEMIA

HYPERFIBRINOGENAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TOVORAFENIB 1 0.0031
1 THIOTEPA 12 0.0012
2 PROPAFENONE 5 0.0012
3 ANTI-THYMOCYTE GLOBULIN (RABBIT) 9 0.0011
4 VINORELBINE 7 0.0010
5 IXABEPILONE 1 0.0010
6 TRIPTORELIN 3 0.0009
7 BUSULFAN 12 0.0008
8 CLINDAMYCIN PHOSPHATE 4 0.0007
9 AMINOPHYLLINE 1 0.0005
See all drugs enriched for association with HYPERFIBRINOGENAEMIA